Genmab | Crediti Commerciali



Trade Debtors Cambiamento Data
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Almirall EUR 178.14M 31.11M 2024-06
Amarin USD 112.64M 11.05M 2024-09
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Bayer EUR 12.5B 1.33B 2024-12
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Demant DKK 4.45B 141M 2024-12
Exelixis USD 265.44M 4.27M 2025-01
Fresenius Medical Care EUR 3.37B 123M 2024-12
Galapagos EUR 83.49M 3.87M 2025-03
Genmab DKK 6.69B 381M 2024-12
GlaxoSmithKline GBP 7.5B 176M 2025-03
GN Store Nord DKK 386M 4.58B 2024-12
GRIFOLS EUR 871.58M 135.79M 2024-12
Hikma Pharmaceutical USD 965M 92M 2024-06
Insmed USD 52.01M 9.7M 2024-12
Lonza CHF 2B 406M 2024-12
Merck EUR 4.59B 127M 2024-12
Novartis USD 9B 854M 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
UCB EUR 1.42B 132M 2024-06



Genmab Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.